Morgan Atkinson

Mr. Morgan Atkinson


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
MAMorgan Atkinson
Morgan Atkinson
AMAndrew Murnane
Andrew Murnane
TGThomas Goddard
Thomas Goddard
CPCathy Pendergrast
Cathy Pendergrast
PRPaul Rogers
Paul Rogers
MOMichael Osborn
Michael Osborn

16 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MAMorgan Atkinson
Morgan Atkinson
ATAngela Tully
Angela Tully
CMCarol A. Maher
Carol A. Maher
CIChris Innes-Wong
Chris Innes-Wong
RRRay N. Russo
Ray N. Russo
MOMichael Osborn
Michael Osborn
Background: Rehabilitation robotics is a field of study which aims to understand and augment rehabilitation through the use of robotics devices. Objective: This proof of concept study aimed to test the safety (no. adverse events, incidence of infection), feasibility (program demand, adherence, participant satisfaction) and efficacy (Peak Oxygen uptake (VO2peak), 6-min walk test, gait speeds, Canadian Occupational Performance Measure, quality of life) of Lokomat® and Armeo®Spring training in children and adolescents and young adults (AYAs) during or soon after cancer treatment. Method: This was a 6-week single arm pre-post study. Cancer patients with significant musculoskeletal, neurological, gait and/or upper limb deficiency aged 5 to 25 years were recruited. The rehabilitation program included access to two robotic orthoses: the Lokomat® and/or Armeo®Spring. Robotic devices utilised real-time biofeedback and computer games to engage and guide participants through a repetitive functional range of movement aimed at improving functional deficiencies. Progressive increases in exercise intensity and duration were encouraged. Results: Twentey-eight participants were approached for study; twenty-one consented. Seventy-six percent completed the six-week intervention with an overall adherence of 83%. The mean participant satisfaction score was 8.8/10. Forty-nine adverse events were recorded throughout the course of the study, forty-five grade 1, three grade 2 and one grade 3. No adverse events led to withdrawal from the study. Preliminary efficacy results indicate large beneficial effects on VO2peak (r = 0.63), 10 m comfortable pace walk (r = 0.51) and maximal pace walk (r = 0.60), 6-min walk test (r = 0.60), maximal back and leg strength (r = 0.71), trunk flexibility (r = 0.60), The European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C30) (r = 0.61), Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT F) r = 0.53 and the Canadian Occupational Performance Measure, satisfaction (r = 0.88) and performance scores (r = 0.83), and moderate beneficial effects on Leisure Score Index (LSI) (r = 0.30). Conclusion: Our results suggest that Lokomat® and Armeo®Spring training is safe and feasible for use in children and AYAs who are currently undergoing or have recently completed cancer therapy. A larger controlled trial investigating the efficacy of robotics rehabilitation in this cohort is warranted.

5 September 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
KNKarlee Naumann
Karlee Naumann
BSBen Singh
Ben Singh
SBSamuel Peter Bushaway
Samuel Peter Bushaway
RCRhiannon Crane
Rhiannon Crane
SDSwapna Deepak
Swapna Deepak
CMCarol Maher
Carol Maher
Background Assessing multidisciplinary prehabilitation strategies becomes crucial to pre-emptively counter the physical, psychological and social negative impacts experienced during an allogenic haematopoietic stem cell transplant (allo-HSCT) among acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) patients. Current evidence is restricted to studies during induction chemotherapy, omitting rehabilitation interventions and predominantly using exercise-only approaches without a multidisciplinary framework. The aim of this study is to investigate the feasibility, safety and preliminary efficacy of multidisciplinary prehabilitation in adults offered allo-HSCT. Methods and analysis This 8-week single-group pre-post feasibility study aims to pilot a multidisciplinary prehabilitation intervention for participants undergoing allo-HSCT, with a focus on feasibility and safety. Participants, aged 18 or older, diagnosed with AML or MDS, and offered allo-HSCT, will be recruited between June 2023 and July 2024. The multidisciplinary prehabilitation intervention, conducted by the cancer allied health team at the Royal Adelaide Hospital, includes exercise physiology, physiotherapy, dietetics, social work, occupational therapy and psychology interventions. Consistent with a multidisciplinary treatment approach, each component is tailored to address different aspects of patient care, and adherence calculations will assess patient engagement and compliance. In addition, participants will continue to receive usual care from cancer allied health staff. The primary outcome of the study is to assess the feasibility of a multidisciplinary prehabilitation intervention by evaluating intervention uptake, retention, adherence, acceptability and safety. Secondary outcomes are leg strength, upper-body strength, aerobic fitness, falls risk, anthropometry, nutritional status, quality of life, anxiety, depression, self-efficacy for coping with cancer and distress. Ethics and dissemination Ethics approval for this study has been provided by the Central Adelaide Local Health Network (HREC 2022/HRE00284). Recruitment for the study commenced in June 2023 and will continue until July 2024. The methods have been designed and are reported according to the SPIRIT and CONSORT-pilot study checklist. Trial registration number The Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12623000052639.

29 June 2021 in Asia-Pacific Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
DMDavid Mizrahi
David Mizrahi
AMAndrew Murnane
Andrew Murnane
SQSharni Quinn
Sharni Quinn
JCJessica Crowe
Jessica Crowe
SRSimon Rosenbaum
Simon Rosenbaum
MAMorgan Atkinson
Morgan Atkinson

22 August 2026 in Cancer Survivorship Research & Care
Verified
Journal Article
Open access
KSKelly Skelton
Kelly Skelton
SJSophie Jessop
Sophie Jessop
MAMorgan Atkinson
Morgan Atkinson
GVGabrielle Vigar
Gabrielle Vigar
MJMelissa Jones
Melissa Jones
MSMichala Short
Michala Short